Your browser doesn't support javascript.
loading
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study.
Kim, Dae Jung; Sheu, Wayne H-H; Chung, Wook-Jin; Yabe, Daisuke; Ha, Kyoung Hwa; Nangaku, Masaomi; Tan, Elise Chia-Hui; Node, Koichi; Yasui, Atsutaka; Lei, Weiyu; Lee, Sunwoo; Saarelainen, Laura; Deruaz-Luyet, Anouk; Kyaw, Moe H; Seino, Yutaka.
Affiliation
  • Kim DJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
  • Sheu WH; Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chung WJ; Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea.
  • Yabe D; Kansai Electric Power Medical Research Institute, Kobe, Japan.
  • Ha KH; Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Nangaku M; Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan.
  • Tan EC; Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Node K; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
  • Yasui A; Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan.
  • Lei W; National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan.
  • Lee S; Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan.
  • Saarelainen L; Department of Cardiovascular Medicine, Saga University, Saga, Japan.
  • Deruaz-Luyet A; Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan.
  • Kyaw MH; Boehringer Ingelheim Taiwan Ltd, Taipei, Taiwan.
  • Seino Y; Boehringer Ingelheim Korea Ltd, Seoul, South Korea.
J Diabetes Investig ; 14(3): 417-428, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36716212
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors / Myocardial Infarction Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: Asia Language: En Journal: J Diabetes Investig Year: 2023 Document type: Article Affiliation country: South Korea Country of publication: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors / Myocardial Infarction Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: Asia Language: En Journal: J Diabetes Investig Year: 2023 Document type: Article Affiliation country: South Korea Country of publication: Japan